A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma

BACKGROUND: Concurrent treatment with temozolomide and radiotherapy followed by maintenance temozolomide is the standard of care for patients with newly diagnosed glioblastoma. Bevacizumab, a humanized monoclonal antibody against vascular endothelial growth factor A, is currently approved for recurr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Gilbert, Mark R., Dignam, James J., Armstrong, Terri S., Wefel, Jeffrey S., Blumenthal, Deborah T., Vogelbaum, Michael A., Colman, Howard, Chakravarti, Arnab, Pugh, Stephanie, Won, Minhee, Jeraj, Robert, Brown, Paul D., Jaeckle, Kurt A., Schiff, David, Stieber, Volker W., Brachman, David G., Werner-Wasik, Maria, Tremont-Lukats, Ivo W., Sulman, Erik P., Aldape, Kenneth D., Curran, Walter J., Mehta, Minesh P.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2014
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4201043/
https://ncbi.nlm.nih.gov/pubmed/24552317
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1308573
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge